{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:33:01Z","timestamp":1790339581035,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.jaad.2004.03.047","type":"journal-article","created":{"date-parts":[[2004,9,24]],"date-time":"2004-09-24T23:13:32Z","timestamp":1096067612000},"page":"660-662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Aggressive cutaneous T-cell lymphomas after TNF\u03b1 blockade"],"prefix":"10.1016","volume":"51","author":[{"given":"Amy E.","family":"Adams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Zwicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Curiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall E.","family":"Kadin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"Falchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reed","family":"Drews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Kupper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2004.03.047_bib1","first-page":"7","article-title":"Inhibitors of tumor necrosis factor for rheumatoid arthritis","volume":"26","author":"Moreland","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2004.03.047_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00054725-199905000-00008","article-title":"Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety","volume":"5","author":"Sandborn","year":"1999","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaad.2004.03.047_bib3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00063030-200317030-00005","article-title":"Role of novel biological therapies in psoriatic arthritis: effects on joints and skin","volume":"17","author":"Braun","year":"2003","journal-title":"BioDrugs"},{"key":"10.1016\/j.jaad.2004.03.047_bib4","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.03.047_bib5","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.4049\/jimmunol.160.12.6072","article-title":"Blockade of endogenous TNF-alpha exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms","volume":"160","author":"Allendoerfer","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2004.03.047_bib6","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1002\/art.10679","article-title":"Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration","volume":"46","author":"Brown","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2004.03.047_bib7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0889-8588(18)30052-2","article-title":"Epidemiology and clinical manifestations of cutaneous T-cell lymphoma","volume":"5","author":"Koh","year":"1995","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jaad.2004.03.047_bib8","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/1097-0142(19820915)50:6<1181::AID-CNCR2820500625>3.0.CO;2-P","article-title":"Central nervous system involvement in mycosis fungoides: diagnosis treatment and literature review","volume":"50","author":"Bodensteiner","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2004.03.047_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archderm.1983.01650280039013","article-title":"Mycosis fungoides of the mastoid, middle ear, and CNS","volume":"119","author":"Zackheim","year":"1983","journal-title":"Arch Derm"},{"key":"10.1016\/j.jaad.2004.03.047_bib10","first-page":"723","article-title":"Mycosis fungoides mit Beteiligung des Zentralnervensystems","volume":"43","author":"Bushke","year":"1933","journal-title":"Zentralbl Haut Geschlechtskr"},{"key":"10.1016\/j.jaad.2004.03.047_bib11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0190-9622(93)70201-4","article-title":"Cutaneous T-cell lymphoma associated with HIV infection","volume":"29","author":"Burns","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.03.047_bib12","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1067\/mjd.2002.106357","article-title":"Cutaneous T-cell lymphoma developing in a patient on cyclosporin therapy","volume":"47","author":"Kirby","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.03.047_bib13","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1126\/science.1071924","article-title":"TNF-R1 signaling: a beautiful pathway","volume":"296","author":"Chen","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jaad.2004.03.047_bib14","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJM199912093412407","article-title":"Inflammatory skin diseases, T cells and immune surveillance","volume":"341","author":"Robert","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.03.047_bib15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1006\/smim.1998.0156","article-title":"CD30: expression and function in health and disease","volume":"10","author":"Horie","year":"1998","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jaad.2004.03.047_bib16","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1128\/MCB.17.3.1535","article-title":"Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2","volume":"17","author":"Duckett","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jaad.2004.03.047_bib17","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/jlb.57.5.726","article-title":"CD30 and type 2 T helper (Th2) responses","volume":"57","author":"Romagnani","year":"1995","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaad.2004.03.047_bib18","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1074\/jbc.272.4.2042","article-title":"Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NF\u03baB activation","volume":"272","author":"Aizawa","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaad.2004.03.047_bib19","doi-asserted-by":"crossref","first-page":"9699","DOI":"10.1073\/pnas.93.18.9699","article-title":"CD30\/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity","volume":"93","author":"Lee","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jaad.2004.03.047_bib20","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1182\/blood.V83.8.2045.2045","article-title":"Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines","volume":"83","author":"Gruss","year":"1994","journal-title":"Blood"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204012745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962204012745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:35:48Z","timestamp":1759268148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962204012745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0190962204012745"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2004.03.047","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aggressive cutaneous T-cell lymphomas after TNF\u03b1 blockade","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2004.03.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}